Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

Five-year patient-reported normal tissue effects suggest 26 Gy/5Fr/1-week hypofractionation is safe for breast cancer patients requiring adjuvant axillary radiotherapy.

Authors

Institutions

Publication Details

Journal
Radiotherapy and Oncology
Published
2025-05-04
DOI
https://doi.org/10.1016/j.radonc.2025.110915
Citations
11
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
10.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

Judith Sinclair, Judith M. Bliss, Navita Somaiah, Jaymini Patel et al.
11 citations
Radiotherapy and Oncology
Breast Cancer Treatment Studies
10.30
article

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study

Judith Sinclair, Judith M. Bliss, Navita Somaiah, Jaymini Patel, Karen Venables, Duncan Wheatley, Clare Griffin, Mark Sydenham, John Yarnold, Joanne Haviland, Susan Cleator, Fay Cafferty, Zohal Nabi, Abdulla Alhasso, Adrian Murray Brunt, Cliona Kirwan, Elinor J. Sawyer, Anna M. Kirby, Helen Fleming, Daljit Gahir, Charlie Chan, Charlotte E. Coles, Karen Poole, Isabel Syndikus, Andy Goodman
article en
11 citations

Abstract

Five-year patient-reported normal tissue effects suggest 26 Gy/5Fr/1-week hypofractionation is safe for breast cancer patients requiring adjuvant axillary radiotherapy.

Radiotherapy and OncologyVol. 207
Guy's Hospital (GB), Cheltenham General Hospital (GB), St Thomas' Hospital (GB), Royal Marsden NHS Foundation Trust (GB), Institute of Cancer Research (GB), Imperial College Healthcare NHS Trust (GB), University of Cambridge (GB), Royal Cornwall Hospital Trust (GB), Royal Cornwall Hospital (GB), University Hospitals of North Midlands NHS Trust (GB), Beatson West of Scotland Cancer Centre (GB), Torbay Hospital (GB), Clatterbridge Cancer Centre NHS Foundation Trust (GB), Manchester University NHS Foundation Trust (GB), Nuffield Health (GB), Patient Advocate Foundation (US), Mount Vernon Hospital (GB), Keele University (GB)
Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, Health Technology Assessment Programme, NIHR Cambridge Biomedical Research Centre
Good health and well-being
Openalex Percentile: Top 1%
Breast Cancer Treatment Studies
10.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.